Orange Book product · Brand (NDA)

PRISTIQ

DESVENLAFAXINE SUCCINATE

Brand (NDA)NDA 021992TE ABRX PF PRISM CV

Aug 20, 2014

Approved

Brand (NDA)

Application

TE code

Listed patents

Approval
FDA approval date of this drug product.
Aug 20, 2014
12 yr ago
Today
Patent 8269040 expires
Listed drug substance patent expiration.
Jul 05, 2027
in 1 yr 1 mo

Active ingredient

DESVENLAFAXINE SUCCINATE

Strength

EQ 25MG BASE

Dosage form

TABLET, EXTENDED RELEASE

Route

ORAL

TE code

Application

NDA 021992

Product number

003

Marketing status

Reference listed drug (RLD)

Yes

Reference standard (RS)

Active-ingredient family

This is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.

Patents listed in the FDA Orange Book for this product, with expiration date and patent type.
Patent	Expires	In	Type
8269040	Jul 05, 2027	in 1 yr 1 mo	Substance